David Buchbinder

Summary

Affiliation: Children's Hospital of Orange County
Country: USA

Publications

  1. doi request reprint Newborn screening for severe combined immunodeficiency: an opportunity for intervention
    D Buchbinder
    Division of Hematology CHOC Children s Hospital and UC Irvine Medical Center, Orange, CA, USA
    J Perinatol 33:657-8. 2013
  2. doi request reprint Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Pediatr Transplant 17:E104-7. 2013
  3. doi request reprint Successful cord blood transplantation in a patient with malignant infantile osteopetrosis and hemophilia
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Pediatr Transplant 17:E20-4. 2013
  4. doi request reprint Inflammatory polyps following successful HLA-matched cord blood transplantation in a patient with X-linked lymphoproliferative syndrome
    David Buchbinder
    Divisions of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Pediatr Transplant 16:E188-91. 2012
  5. doi request reprint X-linked hyper IgM syndrome: a novel sequence variant associated with an atypical mild phenotype
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    J Pediatr Hematol Oncol 34:e212-4. 2012
  6. doi request reprint Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital and UC Irvine Medical Center, Orange, CA 92868, USA
    Pediatr Transplant 16:E69-73. 2012
  7. pmc Cancer prevention and screening practices of siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study
    David Buchbinder
    Department of Pediatrics and Division of Hematology at Children s Hospital of Orange County, Orange, CA 92868, USA
    Cancer Epidemiol Biomarkers Prev 21:1078-88. 2012
  8. pmc Psychological outcomes of siblings of cancer survivors: a report from the Childhood Cancer Survivor Study
    David Buchbinder
    Department of Pediatrics and Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Psychooncology 20:1259-68. 2011
  9. doi request reprint A patient with familial bone marrow failure and an inversion of chromosome 8
    David Kyle Buchbinder
    Division of Hematology, Children s Hospital of Orange County, Orange, CA, USA
    J Pediatr Hematol Oncol 33:626-7. 2011
  10. doi request reprint Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics?
    David Buchbinder
    Division of Pediatric Hematology, Children s Hospital Orange County, University of California at Irvine, Orange, CA, USA
    J Clin Immunol 31:773-7. 2011

Detail Information

Publications16

  1. doi request reprint Newborn screening for severe combined immunodeficiency: an opportunity for intervention
    D Buchbinder
    Division of Hematology CHOC Children s Hospital and UC Irvine Medical Center, Orange, CA, USA
    J Perinatol 33:657-8. 2013
    ....
  2. doi request reprint Successful autologous cord blood transplantation in a child with acquired severe aplastic anemia
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Pediatr Transplant 17:E104-7. 2013
    ..This case serves to discuss approaches to preparative therapy as well as the potential complications in this growing cohort of patients...
  3. doi request reprint Successful cord blood transplantation in a patient with malignant infantile osteopetrosis and hemophilia
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Pediatr Transplant 17:E20-4. 2013
    ..Given the underlying diagnosis of MIOP and need for HCT, the challenge of mitigating the significant risk of bleeding in a patient with a comorbid bleeding disorder is discussed...
  4. doi request reprint Inflammatory polyps following successful HLA-matched cord blood transplantation in a patient with X-linked lymphoproliferative syndrome
    David Buchbinder
    Divisions of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Pediatr Transplant 16:E188-91. 2012
    ..Given the underlying diagnosis of XLP and its associated immune dysregulation, the challenge of understanding unique gastrointestinal manifestations of autoimmunity following HSCT is discussed...
  5. doi request reprint X-linked hyper IgM syndrome: a novel sequence variant associated with an atypical mild phenotype
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    J Pediatr Hematol Oncol 34:e212-4. 2012
    ..The clinical implications of this mutation and associated atypical phenotype are discussed...
  6. doi request reprint Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital and UC Irvine Medical Center, Orange, CA 92868, USA
    Pediatr Transplant 16:E69-73. 2012
    ..Given the challenges of HSCT in any patient with CDA and severe iron overload, the role of novel approaches to iron chelation and HSCT is discussed...
  7. pmc Cancer prevention and screening practices of siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study
    David Buchbinder
    Department of Pediatrics and Division of Hematology at Children s Hospital of Orange County, Orange, CA 92868, USA
    Cancer Epidemiol Biomarkers Prev 21:1078-88. 2012
    ..To compare the skin and breast/cervical cancer prevention/screening practices of adult siblings of childhood cancer survivors with controls and to identify modifying factors for these practices...
  8. pmc Psychological outcomes of siblings of cancer survivors: a report from the Childhood Cancer Survivor Study
    David Buchbinder
    Department of Pediatrics and Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    Psychooncology 20:1259-68. 2011
    ..To identify risk factors for adverse psychological outcomes among adult siblings of long-term survivors of childhood cancer...
  9. doi request reprint A patient with familial bone marrow failure and an inversion of chromosome 8
    David Kyle Buchbinder
    Division of Hematology, Children s Hospital of Orange County, Orange, CA, USA
    J Pediatr Hematol Oncol 33:626-7. 2011
    ..3)]. Given the importance of considering the genetic determinants of familial bone marrow failure, the potential role of chromosome 8 abnormalities in the development of marrow failure is discussed...
  10. doi request reprint Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics?
    David Buchbinder
    Division of Pediatric Hematology, Children s Hospital Orange County, University of California at Irvine, Orange, CA, USA
    J Clin Immunol 31:773-7. 2011
    ..Characterization of the potential epigenetic contribution to the spectrum of XLT and WAS is described and the implications of these findings are discussed...
  11. doi request reprint Meeting the psychosocial needs of sibling survivors: a family systems approach
    David Buchbinder
    Division of Hematology, CHOC Children s Hospital, Orange, CA 92868, USA
    J Pediatr Oncol Nurs 28:123-36. 2011
    ..Identification of the impact of survivorship on the long-term psychosocial health of sibling survivors may help ensure the long-term psychosocial health of all survivors...
  12. doi request reprint Moyamoya in a child treated with interferon for recurrent osteosarcoma
    David Buchbinder
    Division of Hematology, Department of Pediatrics, Children s Hospital of Orange County, Main Street, Orange, USA
    J Pediatr Hematol Oncol 32:476-8. 2010
    ..Given the importance of characterizing late effects after the treatment of childhood cancer, the potential role of interferon alpha in the development of moyamoya is discussed...
  13. doi request reprint Inappropriate sinus tachycardia after hematopoietic stem cell transplantation
    David Buchbinder
    Department of Pediatric Hematology and Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    J Pediatr Hematol Oncol 32:15-8. 2010
    ..The clinical importance of this late cardiac effect along with the potential options for therapy is discussed...
  14. pmc Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue
    David Buchbinder
    Department of Pediatric Hematology, Children s Hospital of Orange County, 455 S Main Street, Orange, CA 92868, USA
    J Neurooncol 97:429-37. 2010
    ..The use of intensive chemotherapy followed by autologous stem cell rescue for atypical neurocytoma may be considered as an adjunct to surgical therapy in young patients with atypical neurocytoma not amenable to radiation therapy...
  15. pmc Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study
    Lonnie K Zeltzer
    Department of Pediatrics, Division of Cancer Prevention and Control Research, David Geffen School of Medicine at University of California Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095 1752, USA
    J Clin Oncol 27:2396-404. 2009
    ..These findings suggest targeting interventions for groups at highest risk for adverse outcomes and examining the positive growth that remains despite the trauma of childhood cancer...
  16. pmc Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research
    David Buchbinder
    Department of Hematology, Children s Hospital of Orange County, Orange, California, USA
    Biol Blood Marrow Transplant 18:1776-84. 2012
    ..0), and cataracts 5.1% (95% CI: 2.9-8.0). Our results indicated that all patients undergoing HCT for SAA remain at risk for late effects, must be counseled about, and should be monitored for late effects for the remainder of their lives...